Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Platelet enzymes refers to a broad category of catalytic proteins found within platelets that regulate blood clotting and vascular integrity. Key enzymes within this group include Cyclooxygenase-1 (COX-1), which is essential for thromboxane A2 synthesis, and Phosphodiesterase 3 (PDE3), which regulates intracellular cyclic AMP levels. These enzymes are critical for platelet activation and aggregation in response to vascular injury. Because of their central role in thrombus formation, specific platelet enzymes are major therapeutic targets for antiplatelet drugs used to prevent myocardial infarction and stroke. However, Platelet enzymes is considered an overly broad or non-specific target designation for drug discovery purposes, as therapeutic agents typically target a single, specific enzyme within this group rather than the entire class.
Inhibition of specific enzymatic pathways (e.g., cyclooxygenase or phosphodiesterase) to prevent platelet aggregation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet enzymes.